Lymphangitis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Changes made per Mahshid's request)
Line 22: Line 22:
== Reference ==
== Reference ==
[[Category:Inflammations]]
[[Category:Inflammations]]
[[Category:Infectious disease]]
 
[[Category:Disease]]
[[Category:Disease]]
[[Category:Needs content]]
[[Category:Needs content]]

Revision as of 18:15, 18 September 2017

Lymphangitis Microchapters

Home

Overview

Historical Perspective

Classification

Causes

Pathophysiology

Differentiating Lymphangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Case Studies

Case #1

Lymphangitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphangitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphangitis epidemiology and demographics

CDC on Lymphangitis epidemiology and demographics

Lymphangitis epidemiology and demographics in the news

Blogs on Lymphangitis epidemiology and demographics

Directions to Hospitals Treating Lymphangitis

Risk calculators and risk factors for Lymphangitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]

Overview

Lymphangitis being a manifestation of wider concurrently occurring spectrum of manifestations or pathologies. The epidemiology and demographics of this individual manifestation are poorly studied

Epidemiology and demographics

Lymphangitis being a manifestation of wider concurrently occurring spectrum of manifestations or pathologies. The epidemiology and demographics of this individual manifestation are poorly studied. Epidemiology and demographics of lymphangitis carcinomatosis and sclerosing lymphangitis are discussed below:

Lymphangits carcinomatosis

Epidemiology

Lymphangitis carcinomatosis occurs in 6-8% of the intra-thoracic metastasis from a malignant disease.[1]

Demographically

Higher prevalence of lymphangitis carcinomatosis is reported in males, when compared to females(60:40) and younger population.[1]

Sclerosing lymphangitis

Epidemiology and demographics

Incidence and prevalence of sclerosing lymphangitis is poorly studies. Demographically, it mostly occurs in younger male population between 20-40 years of age.[2]

Reference

  1. 1.0 1.1 Bruce DM, Heys SD, Eremin O (1996). "Lymphangitis carcinomatosa: a literature review". J R Coll Surg Edinb. 41 (1): 7–13. PMID 8930034.
  2. Papeš D, Altarac S, Antabak A, Savić I (2015). "Nonvenereal sclerosing lymphangitis of the penis". Acta Dermatovenerol Croat. 23 (2): 150–1. PMID 26228831.